Acute and Short-Term Effects of Clonidine in Heart Failure
- The Impact of Baseline HR and BP on the Tolerability of Carvedilol in the Elderly: The COLA (Carvedilol Open Label Assessment) II Study. MacDonald, Peters S.; Hill, Julie; Krum, Henry // American Journal of Cardiovascular Drugs;2006, Vol. 6 Issue 6, p401
BACKGROUND: The COLA (Carvedilol Open Label Assessment) II Study prospectively evaluated the tolerability of carvedilol in 1030 patients >70 years of age with chronic heart failure (CHF). Tolerability, defined as patients receiving â‰¥3 months of carvedilol and achieving a maintenance...
- Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Conraads, Viviane M.; Metra, Marco; Kamp, Otto; De Keulenaer, Gilles W.; Pieske, Burkert; Zamorano, Jos�; Vardas, Panos E.; B�hm, Michael; Dei Cas, Livio // European Journal of Heart Failure;Feb2012, Vol. 14 Issue 2, p219
Aims We hypothesized that nebivolol, a beta-blocker with nitric oxide-releasing properties, could favourably affect exercise capacity in patients with heart failure and preserved left ventricular ejection fraction (HFPEF). Methods and results A total of 116 subjects with HFPEF, in New York Heart...
- Should calcium channel blockers be used as first-line antihypertensive therapy? Reust, Carin E. // Journal of Family Practice;Mar2001, Vol. 50 Issue 3, p258
The article discusses whether calcium channel blockers (CCB) be used as a first-line treatment for hypertension. Compared to placebo, CCB are more effective in decreasing blood pressure. However, studies and controlled trials show that although CCB decreases blood pressure, it increases...
- PIII-8. Kurnik, D.; Friedman, E. A.; Muszkat, M.; Sofowora, G. G.; Xie, H. G.; Harris, P. A.; Wood, A. J.; Stein, C. M. // Clinical Pharmacology & Therapeutics;Feb2006, Vol. 79 Issue 2, pP60
Background: Clonidine, a mixed Î±2-(ADRA2) and Î±1- (ADRA1) adrenergic receptor agonist, decreased blood pressure more in Caucasians (C) than African-Americans (AA) despite a similar decline in sympathetic activity. This difference could be explained by ethnic differences in clonidine's...
- GUIDE TO INTERVIEW QUESTIONS. // Journal of Gerontological Nursing;May2005, Vol. 31 Issue 5, p23
Offers a guide to the questions that gerontologists should ask their patients who are suffering from heart failure. Weight concerns; Blood pressure; Exercise; Medications.
- Reducing mild hypertension in older people. // Journal of Business (10756124);7/14/2005, Vol. 20 Issue 15, pB7
Reports on a study which claims that moderate levels of exercise may not be enough to control mild hypertension in people over age 55, the age group most at risk of later developing potentially fatal heart failure. Research's suggestion that exercise alone might not help in lowering blood...
- Evaluation of exercise capacity using wave intensity in chronic heart failure with normal ejection fraction. Takaya, Yoichi; Taniguchi, Manabu; Sugawara, Motoaki; Nobusada, Saori; Kusano, Kengo; Akagi, Teiji; Ito, Hiroshi // Heart & Vessels;Mar2013, Vol. 28 Issue 2, p179
Impaired exercise capacity has been found in patients with diastolic dysfunction with preserved systolic function. Although conventional transthoracic echocardiography (TTE) provides useful clinical information about systolic and diastolic cardiac function, its capability to evaluate exercise...
- Heart Failure and Tachycardia: A Worrisome Combination. Grais, Martin; Miller, Albert J. // Cortlandt Forum;11/25/2002, Vol. 15 Issue 11, p25
Focuses on the treatment of the patient with heart failure and sinus tachycardia. Examination on the medical history of the patient; Observation of the blood pressure; Importance of physical examination.
- Effects of Carvedilol in the treatment of heart failure. Huffman, Grace Brooke // American Family Physician;6/1/1997, Vol. 55 Issue 8, p2834
Presents a summary of the article `Double-blind, Placebo-controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure. The PRECISE Trial,' by M. Packer, et al from `Circulation' dated 1996. Scope of the study; Findings of the study.